A Phase 1, Double-Blind, Placebo-Controlled, Sponsor-Open, Randomized, Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-03654746 in Mild to Moderate Alzheimer's Disease Patients on Stable Donepezil Therapy.
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2014
At a glance
- Drugs PF 3654746 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 03 Jun 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 27 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jul 2010 Actual initiation date changed from 1 Jan 2010 to 1 Dec 2009 as reported by ClinicalTrials.gov.